Hot Product

Highly Accurate Cotinine Urine HAV Rapid Test - TZcheck

Short Description:

The HAV Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to Hepatitis A virus (HAV) in whole blood, serum or plasma specimen.

 

Place of Origin:China
Brand name:TZcheck

Certification:CE


Product Detail

Product Tags

At Tongzhou Biotechnology, we are committed to delivering high-quality diagnostic solutions to meet the needs of healthcare professionals and their patients. Our flagship product, the TZcheck HAV Rapid Test, is specifically designed for fast and accurate detection of Hepatitis A Virus (HAV) in Cotinine Urine. This advanced diagnostic tool leverages cutting-edge technology to provide healthcare providers with the confidence and reliability they demand in their testing processes. With the increasing prevalence of HAV, prompt and precise detection is crucial in managing and controlling outbreaks. The TZcheck HAV Rapid Test stands out as a vital resource in this endeavor, offering exceptional sensitivity and specificity.

  1. HAV Rapid Test


  • Cat. No.

    Product Description

    Specimen

    Format

    Kit Size

    Cut-Off

    Status

    I082-4002

    HAV IgM Rapid Test

    WB/S/P

    Cassette

    25/20/10T

    See Insert

    CE

    I083-4025

    HAV IgG/IgM Combo Rapid Test

  • HAV is a positive RNA virus, a unique member of picornavirdae. Its transmission depends primarily on serial transmission from person to person by the fecal-oral route. Although hepatitis A is not ordinarily a sexually transmitted disease, the infection rate is high among male homosexuals, as result of oral-anal contact.

    The HAV IgG/IgM Combo Rapid Test (Whole Blood/Serum/Plasma) is to be used to detect IgG and IgM antibodies to HAV in less than 15 minutes by untrained or minimally skilled personnel, without cumbersome laboratory equipment.



The TZcheck HAV Rapid Test is engineered to provide results in a swift and efficient manner. Using just a small sample of Cotinine Urine, this test can deliver conclusive results in under 15 minutes. This rapid turnaround time is essential for healthcare settings where timely decision-making can significantly impact patient outcomes. Additionally, the TZcheck HAV Rapid Test is designed to be user-friendly, requiring minimal training for medical personnel. Its straightforward procedure ensures that healthcare providers can seamlessly integrate the test into their routine workflows, thus enhancing overall efficiency and productivity. Beyond the speed and ease of use, the TZcheck HAV Rapid Test is distinguished by its high accuracy. It utilizes an advanced immunoassay technique to detect HAV antibodies in Cotinine Urine with remarkable precision. This high level of accuracy reduces the likelihood of false positives and false negatives, thereby ensuring that patients receive the correct diagnosis and appropriate care without unnecessary delays. Furthermore, the test is constructed with robust quality control measures, ensuring consistent performance and reliability across various testing scenarios. Tongzhou Biotechnology’s commitment to excellence is reflected in every aspect of the TZcheck HAV Rapid Test, making it an indispensable tool for healthcare professionals focused on effective HAV management.

  • Previous:
  • Next:
  • Leave Your Message